Antibiotics should not be given to patients with acute purulent rhinitis (a runny nose with colored discharge), a familiar feature of the common cold, concludes a study published in the online version of the British Medical Journal (bmj.com) today.
General practitioners often prescribe antibiotics for respiratory tract infections when nasal discharge is purulent. Most guidelines recommend against their use for this condition, but this advice is based on one study that showed no effect.
So researchers in New Zealand searched the scientific literature for trials comparing antibiotics with placebo for acute purulent rhinitis (duration less than 10 days).
They identified seven trials. Pooling the results showed that antibiotics for acute purulent rhinitis may be beneficial. The numbers needed to treat ranged from 7 to 15, meaning that, at best, six patients get no benefit for every one who gets benefit. Harms attributed to antibiotics were mainly vomiting, diarrhea, and abdominal pain, but also included rashes and hyperactivity. The numbers needed to harm ranged from 12 to 78.
No serious harm occurred in the placebo arm in any of the trials. This fits with the medical view that this is not a serious condition, write the authors.
Antibiotics are probably effective for acute purulent rhinitis, say the authors. They can cause harm but most patients will get better without antibiotics.
So, although these findings differ from the guidelines in terms of the effectiveness of antibiotics for acute purulent rhinitis, the authors support the current no antibiotic as first line advice and suggest that antibiotics should be used only when symptoms have persisted for long enough to concern parents or patients.
Source: British Medical Journal
Â
Â
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.